Cerebrovascular disease in COVID-19: Is there a higher risk of stroke?
Marcos Altable1, Juan Moisés de la Serna2
1Private Practice of Neurology, Neuroceuta. (Virgen de África Clinic), Ceuta, Spain.
Insights
COVID-19 is linked to stroke in young adults, even without typical risk factors. Further research is needed to understand the connection between COVID-19 infection and cerebrovascular events.
Area of Science:
- Neurology
- Infectious Diseases
- Cardiovascular Medicine
Background:
- COVID-19 has been associated with stroke in young adults lacking traditional cardiovascular risk factors.
- Cerebrovascular events are typically more prevalent in older individuals with risk factors like hypertension and diabetes.
- There is a growing body of evidence suggesting hypercoagulability as a potential contributor to cerebral ischemia in COVID-19 patients.
Purpose of the Study:
- To review the current literature on cerebrovascular disease (CVD) in the context of COVID-19.
- To explore the epidemiology and etiology of CVD associated with COVID-19.
- To highlight the need for further research into the mechanisms underlying cerebral ischemia in COVID-19.
Main Methods:
- Literature review of case reports and series concerning cerebrovascular disease in COVID-19 patients.
- Analysis of existing data on the association between COVID-19 and stroke.
- Synthesis of evidence regarding hypercoagulability and its role in COVID-19-related cerebral ischemia.
Main Results:
- Reports indicate an increase in stroke cases among young, otherwise healthy adults with COVID-19.
- The precise mechanisms causing cerebral ischemia in COVID-19 remain under investigation.
- Evidence points towards hypercoagulability as a significant factor in COVID-19-associated CVD.
Conclusions:
- COVID-19 may be linked to an increased risk of stroke, particularly in younger populations.
- The development of cerebrovascular disease in COVID-19 patients is complex and not fully understood.
- Further investigation is crucial to elucidate the relationship between COVID-19, hypercoagulability, and cerebrovascular events.
Abstract:
The presence of stroke has been observed in young adults (under fifty years of age) without cardiovascular risk factors who are suffering from COVID-19. It is speculated that there is really a significant increase, as a few cases have yet to be described, or that the infection favors his development. Cerebrovascular events are more common in older patients with stroke risk factors, such as hypertension and diabetes mellitus, and those who have elevated fibrin D-dimers. Multiple case reports and series about cerebrovascular disease (CVD) in COVID-19 has been informed. The mechanism that causes cerebral ischemia in COVID-19 remains undiscovered. However, progressively there is increasing evidence of hypercoagulability that can be or contribute to the cause. We review the current literature about CVD both epidemiology and etiology. More studies are needed to understand.
Related Concept Videos
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Coronary Artery Disease II: Pathophysiology


